Glaukos Corporation Company Profile (NYSE:GKOS)

About Glaukos Corporation (NYSE:GKOS)

Glaukos Corporation logoGlaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm's canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream. It is developing three additional pipeline products: the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is a drug delivery system that is designed to be implanted in the eye to continuously deliver therapeutic levels of medication for extended periods of time to lower intraocular pressure in glaucoma patients.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Devices & Implants
  • Sub-Industry: N/A
  • Symbol: NYSE:GKOS
  • CUSIP: N/A
  • Web: www.glaukos.com
Capitalization:
  • Market Cap: $1.1074 billion
  • Outstanding Shares: 34,434,000
Average Prices:
  • 50 Day Moving Avg: $36.29
  • 200 Day Moving Avg: $36.29
  • 52 Week Range: $28.72 - $52.49
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 87.92
  • P/E Growth: -13.40
Sales & Book Value:
  • Annual Revenue: $139.94 million
  • Price / Sales: 8.00
  • Book Value: $3.66 per share
  • Price / Book: 8.89
Profitability:
  • EBIDTA: $8.15 million
  • Net Margins: -0.81%
  • Return on Equity: 3.52%
  • Return on Assets: 3.06%
Debt:
  • Current Ratio: 6.86%
  • Quick Ratio: 6.42%
Misc:
  • Average Volume: 2.41 million shs.
  • Beta: 1.31
  • Short Ratio: 8.2
 

Frequently Asked Questions for Glaukos Corporation (NYSE:GKOS)

What is Glaukos Corporation's stock symbol?

Glaukos Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "GKOS."

How were Glaukos Corporation's earnings last quarter?

Glaukos Corporation (NYSE:GKOS) issued its quarterly earnings data on Wednesday, March, 1st. The company reported $0.00 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.00 by $0.00. The company earned $33.17 million during the quarter, compared to analysts' expectations of $29.49 million. Glaukos Corporation had a positive return on equity of 3.52% and a negative net margin of 0.81%. The business's revenue was up 63.6% on a year-over-year basis. During the same period last year, the business earned ($0.07) earnings per share. View Glaukos Corporation's Earnings History.

When will Glaukos Corporation make its next earnings announcement?

Glaukos Corporation is scheduled to release their next quarterly earnings announcement on Thursday, November, 9th 2017. View Earnings Estimates for Glaukos Corporation.

Where is Glaukos Corporation's stock going? Where will Glaukos Corporation's stock price be in 2017?

7 brokers have issued 1-year target prices for Glaukos Corporation's shares. Their forecasts range from $38.00 to $60.00. On average, they anticipate Glaukos Corporation's share price to reach $51.33 in the next twelve months. View Analyst Ratings for Glaukos Corporation.

What are analysts saying about Glaukos Corporation stock?

Here are some recent quotes from research analysts about Glaukos Corporation stock:

  • 1. Cantor Fitzgerald analysts commented, "Numbers out of the Way. Yes, 2Q17 revenue growth was impacted several factors: implementation of updated rates and commercial private payers (20% of the market) and sampling by a competitor. Yes, unfortunately these headwinds will remain in place for the rest of the year, coupled with the impact of the hurricanes (TX and FL represents 7% of overall sales). Accordingly, we have lowered our 2017 revenue estimate from $167 million to $158 million. If nothing else happened today, we would perhaps understand the outsized negative reaction (stock is down ~20% intraday)." (9/14/2017)
  • 2. According to Zacks Investment Research, "Glaukos Corporation is an ophthalmic medical technology company. The Company develops, manufactures and markets medical devices for the treatment of glaucoma. Its product pipeline consists of iStent Inject, the iStent Supra and iDose. The company operates primarily in United States, Germany, Europe, the Asia Pacific, Canada and internationally. Glaukos Corporation is headquartered in Laguna Hills, California. " (8/7/2017)

Who are some of Glaukos Corporation's key competitors?

Who are Glaukos Corporation's key executives?

Glaukos Corporation's management team includes the folowing people:

  • William J. Link Ph.D., Independent Chairman of the Board
  • Thomas William Burns, President, Chief Executive Officer and Director
  • Joseph E. Gilliam, Chief Financial Officer, Senior Vice President - Corporate Development
  • Chris M. Calcaterra, Chief Commercial Officer and Chief Operating Officer
  • L. Jay Katz, Chief Medical Officer
  • Mark J. Foley, Independent Director
  • David F. Hoffmeister, Independent Director
  • Gilbert Kliman M.D., Independent Director
  • Jonathan Todd Silverstein J.D., Independent Director
  • Marc A. Stapley, Independent Director

When did Glaukos Corporation IPO?

(GKOS) raised $76 million in an IPO on Thursday, June 25th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan, BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and William Blair and Cantor Fitzgerald were co-managers.

Who owns Glaukos Corporation stock?

Glaukos Corporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Janus Henderson Group PLC (9.06%), Capital World Investors (7.96%), William Blair Investment Management LLC (6.31%), Vanguard Group Inc. (4.85%), Alliancebernstein L.P. (4.75%) and Gilder Gagnon Howe & Co. LLC (4.32%). Company insiders that own Glaukos Corporation stock include Aimee S Weisner, Chris M Calcaterra, Jonathan Silverstein, Montreux Equity Partners Iv Lp, Orbimed Advisors Llc, Richard L Harrison, Thomas William Burns and William J Phd Link. View Institutional Ownership Trends for Glaukos Corporation.

Who sold Glaukos Corporation stock? Who is selling Glaukos Corporation stock?

Glaukos Corporation's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Lord Abbett & CO. LLC, C WorldWide Group Holding A S, Russell Investments Group Ltd., American Century Companies Inc., Bank of Montreal Can, Numeric Investors LLC and Chartwell Investment Partners LLC. Company insiders that have sold Glaukos Corporation stock in the last year include Chris M Calcaterra, Orbimed Advisors Llc, Richard L Harrison, Thomas William Burns and William J Phd Link. View Insider Buying and Selling for Glaukos Corporation.

Who bought Glaukos Corporation stock? Who is buying Glaukos Corporation stock?

Glaukos Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Koch Industries Inc., Bamco Inc. NY, Capital World Investors, Alliancebernstein L.P., Peregrine Capital Management LLC, Wells Fargo & Company MN and State Street Corp. Company insiders that have bought Glaukos Corporation stock in the last two years include Aimee S Weisner and Richard L Harrison. View Insider Buying and Selling for Glaukos Corporation.

How do I buy Glaukos Corporation stock?

Shares of Glaukos Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Glaukos Corporation's stock price today?

One share of Glaukos Corporation stock can currently be purchased for approximately $32.53.


MarketBeat Community Rating for Glaukos Corporation (NYSE GKOS)
Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  174 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  257
MarketBeat's community ratings are surveys of what our community members think about Glaukos Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Glaukos Corporation (NYSE:GKOS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $51.33 (57.80% upside)

Analysts' Ratings History for Glaukos Corporation (NYSE:GKOS)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/15/2017StephensReiterated RatingBuy$47.00MediumView Rating Details
9/15/2017Piper Jaffray CompaniesReiterated RatingPositive -> Buy$38.00HighView Rating Details
9/14/2017Stifel NicolausReiterated RatingBuyHighView Rating Details
9/14/2017Cantor FitzgeraldReiterated RatingBuy$54.00 -> $60.00HighView Rating Details
9/1/2017BMO Capital MarketsReiterated RatingBuy$54.00N/AView Rating Details
8/3/2017Roth CapitalLower Price TargetBuy$60.00 -> $54.00HighView Rating Details
10/27/2016Wells Fargo & CompanyInitiated CoverageOutperformN/AView Rating Details
3/2/2016J P Morgan Chase & CoLower Price TargetOverweight$32.00 -> $28.00N/AView Rating Details
11/19/2015William BlairReiterated RatingOutperformN/AView Rating Details
(Data available from 9/20/2015 forward)

Earnings

Earnings History for Glaukos Corporation (NYSE:GKOS)
Earnings by Quarter for Glaukos Corporation (NYSE:GKOS)
Earnings History by Quarter for Glaukos Corporation (NYSE GKOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017        
3/1/2017Q416$0.00$0.00$29.49 million$33.17 millionViewListenView Earnings Details
11/10/2016Q316($0.01)$0.03$27.21 million$29.60 millionViewN/AView Earnings Details
8/1/2016Q216($0.04)$0.06$24.45 million$28.60 millionViewN/AView Earnings Details
5/3/2016Q116($0.15)$0.03$18.77 million$23.10 millionViewN/AView Earnings Details
3/1/2016Q415($0.13)($0.07)$20.07 million$20.28 millionViewN/AView Earnings Details
11/10/2015Q315($0.17)($0.07)$17.93 million$19.00 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Glaukos Corporation (NYSE:GKOS)
Current Year EPS Consensus Estimate: $0.12 EPS
Next Year EPS Consensus Estimate: $0.37 EPS

Dividends

Dividend History for Glaukos Corporation (NYSE:GKOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Glaukos Corporation (NYSE:GKOS)
Insider Ownership Percentage: 16.40%
Insider Trades by Quarter for Glaukos Corporation (NYSE:GKOS)
Institutional Ownership by Quarter for Glaukos Corporation (NYSE:GKOS)
Insider Trades by Quarter for Glaukos Corporation (NYSE:GKOS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2017Thomas William BurnsCEOSell73,788$41.36$3,051,871.68View SEC Filing  
9/5/2017Orbimed Advisors LlcDirectorSell580,200$38.73$22,471,146.00View SEC Filing  
9/5/2017Thomas William BurnsCEOSell1,212$41.25$49,995.00View SEC Filing  
8/17/2017Orbimed Advisors LlcDirectorSell325,000$37.93$12,327,250.00View SEC Filing  
3/14/2017Orbimed Advisors LlcDirectorSell382,538$45.33$17,340,447.54View SEC Filing  
2/2/2017Thomas William BurnsCEOSell50,000$42.58$2,129,000.00View SEC Filing  
1/13/2017Chris M CalcaterraInsiderSell18,136$40.01$725,621.36View SEC Filing  
1/13/2017Richard L HarrisonCFOSell20,634$40.00$825,360.00View SEC Filing  
1/9/2017Chris M CalcaterraInsiderSell20,000$38.02$760,400.00View SEC Filing  
1/9/2017Thomas William BurnsCEOSell40,000$37.60$1,504,000.00View SEC Filing  
1/6/2017Richard L HarrisonCFOSell20,634$35.58$734,157.72View SEC Filing  
11/17/2016William J Phd LinkDirectorSell30,000$33.78$1,013,400.00View SEC Filing  
11/15/2016Thomas William BurnsCEOSell200,120$33.68$6,740,041.60View SEC Filing  
10/24/2016Chris M CalcaterraInsiderSell20,000$36.01$720,200.00View SEC Filing  
10/20/2016Chris M CalcaterraInsiderSell40,000$34.76$1,390,400.00View SEC Filing  
8/12/2016Jonathan SilversteinDirectorSell292,938$33.69$9,869,081.22View SEC Filing  
8/3/2016Orbimed Advisors LlcDirectorSell425,000$30.59$13,000,750.00View SEC Filing  
7/27/2016Richard L HarrisonCFOSell10,000$35.01$350,100.00View SEC Filing  
7/13/2016Thomas William BurnsCEOSell162,254$30.07$4,878,977.78View SEC Filing  
7/12/2016Richard L HarrisonCFOSell5,700$30.00$171,000.00View SEC Filing  
6/20/2016Richard L HarrisonCFOSell4,300$30.00$129,000.00View SEC Filing  
6/20/2016Thomas William BurnsCEOSell7,997$30.00$239,910.00View SEC Filing  
6/15/2016Chris M CalcaterraInsiderSell45,464$28.46$1,293,905.44View SEC Filing  
6/6/2016Thomas William BurnsCEOSell24,578$25.16$618,382.48View SEC Filing  
6/3/2016Thomas William BurnsCEOSell422$25.00$10,550.00View SEC Filing  
6/1/2016Thomas William BurnsCEOSell25,000$23.90$597,500.00View SEC Filing  
5/25/2016Thomas William BurnsCEOSell300$25.00$7,500.00View SEC Filing  
5/4/2016Chris M CalcaterraInsiderSell74,536$24.40$1,818,678.40View SEC Filing  
5/4/2016Richard L HarrisonCFOSell30,000$24.59$737,700.00View SEC Filing  
5/4/2016Thomas William BurnsCEOSell36,700$24.67$905,389.00View SEC Filing  
3/4/2016Aimee S WeisnerDirectorBuy2,500$16.03$40,075.00View SEC Filing  
2/25/2016Montreux Equity Partners Iv LpMajor ShareholderSell70,000$16.16$1,131,200.00View SEC Filing  
12/31/2015Richard L HarrisonCFOBuy1,388$15.30$21,236.40View SEC Filing  
11/12/2015Aimee S WeisnerDirectorBuy2,500$21.83$54,575.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Glaukos Corporation (NYSE:GKOS)
Latest Headlines for Glaukos Corporation (NYSE:GKOS)
Source:
DateHeadline
thestreet.com logoFirst Week of GKOS November 17th Options Trading
www.thestreet.com - September 19 at 7:03 PM
americanbankingnews.com logoReviewing Stryker Corporation (SYK) & Glaukos Corporation (GKOS)
www.americanbankingnews.com - September 19 at 4:26 PM
finance.yahoo.com logoIs It Too Late To Buy Glaukos Corporation (GKOS)? - Yahoo Finance
finance.yahoo.com - September 16 at 12:43 AM
finance.yahoo.com logoGlaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : September 15, 2017
finance.yahoo.com - September 15 at 7:40 PM
americanbankingnews.com logoGlaukos Corporation (GKOS) Receives Buy Rating from Stephens
www.americanbankingnews.com - September 15 at 5:32 PM
americanbankingnews.com logoGlaukos Corporation (GKOS) Price Target Lowered to $38.00 at Piper Jaffray Companies
www.americanbankingnews.com - September 15 at 8:30 AM
americanbankingnews.com logoGlaukos Corporation (GKOS) Stock Rating Reaffirmed by Stifel Nicolaus
www.americanbankingnews.com - September 14 at 9:50 PM
streetinsider.com logoGlaukos Corporation (GKOS) Trims Q3 and FY Sales Guidance
www.streetinsider.com - September 14 at 7:42 PM
finance.yahoo.com logoGlaukos to Outline Growth Strategy at Investor Day
finance.yahoo.com - September 14 at 7:42 PM
finance.yahoo.com logoIs It Too Late To Buy Glaukos Corporation (GKOS)?
finance.yahoo.com - September 14 at 7:42 PM
finance.yahoo.com logoHere's Why Glaukos Corp. Stock Is Stumbling Today
finance.yahoo.com - September 14 at 7:42 PM
americanbankingnews.com logoGlaukos Corporation (GKOS) Receives "Buy" Rating from Cantor Fitzgerald
www.americanbankingnews.com - September 14 at 4:18 PM
americanbankingnews.com logo$42.58 Million in Sales Expected for Glaukos Corporation (GKOS) This Quarter
www.americanbankingnews.com - September 11 at 9:40 AM
finance.yahoo.com logoIBD Rating Upgrades: Glaukos Flashes Improved Price Strength
finance.yahoo.com - September 8 at 7:34 PM
americanbankingnews.com logoGlaukos Corporation (GKOS) CEO Thomas William Burns Sells 73,788 Shares
www.americanbankingnews.com - September 8 at 7:32 PM
nasdaq.com logoGKOS Crosses Above Key Moving Average Level
www.nasdaq.com - September 7 at 7:15 PM
americanbankingnews.com logoThomas William Burns Sells 1,212 Shares of Glaukos Corporation (GKOS) Stock
www.americanbankingnews.com - September 6 at 10:26 PM
americanbankingnews.com logoGlaukos Corporation (GKOS) Director Sells $22,471,146.00 in Stock
www.americanbankingnews.com - September 5 at 10:26 PM
americanbankingnews.com logoGlaukos Corporation (GKOS) Upgraded to "Hold" at BidaskClub
www.americanbankingnews.com - September 4 at 5:10 PM
americanbankingnews.com logoGlaukos Corporation (GKOS) Stock Rating Reaffirmed by BMO Capital Markets
www.americanbankingnews.com - September 2 at 10:38 AM
finance.yahoo.com logoGlaukos Announces 2017 Investor Day and Webcast
finance.yahoo.com - August 31 at 6:56 PM
americanbankingnews.com logoGlaukos Corporation (GKOS) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 29 at 4:44 PM
americanbankingnews.com logoGlaukos Corporation (GKOS) Cut to "Sell" at BidaskClub
www.americanbankingnews.com - August 26 at 5:30 PM
finance.yahoo.com logoGlaukos Announces Participation in Wells Fargo Healthcare Conference
finance.yahoo.com - August 25 at 6:14 AM
finance.yahoo.com logoGlaukos Announces Participation in Wells Fargo Healthcare Conference
finance.yahoo.com - August 25 at 6:14 AM
americanbankingnews.com logoGlaukos Corporation (GKOS) Expected to Post Quarterly Sales of $42.58 Million
www.americanbankingnews.com - August 23 at 9:10 AM
americanbankingnews.com logoInsider Selling: Glaukos Corp (GKOS) Director Sells 325,000 Shares of Stock
www.americanbankingnews.com - August 17 at 7:20 PM
americanbankingnews.com logoBidaskClub Upgrades Glaukos Corporation (GKOS) to Hold
www.americanbankingnews.com - August 16 at 10:56 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Glaukos Corp.
finance.yahoo.com - August 11 at 7:30 PM
americanbankingnews.com logoZacks Investment Research Lowers Glaukos Corporation (GKOS) to Hold
www.americanbankingnews.com - August 8 at 12:34 AM
americanbankingnews.com logoGlaukos Corporation (GKOS) Downgraded to Sell at BidaskClub
www.americanbankingnews.com - August 5 at 2:56 PM
americanbankingnews.com logoGlaukos Corporation (NYSE:GKOS) Expected to Post Quarterly Sales of $43.20 Million
www.americanbankingnews.com - August 5 at 7:14 AM
americanbankingnews.com logoGlaukos Corporation (GKOS) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - August 5 at 12:40 AM
finance.yahoo.com logoEdited Transcript of GKOS earnings conference call or presentation 2-Aug-17 8:30pm GMT
finance.yahoo.com - August 5 at 12:26 AM
americanbankingnews.com logoGlaukos Corporation (NYSE:GKOS) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 4 at 4:54 PM
streetinsider.com logoGlaukos Corporation (GKOS) Misses Q2 EPS by 15c
www.streetinsider.com - August 4 at 2:26 AM
streetinsider.com logoGlaukos Corporation (GKOS) Misses Q2 EPS by 15c - StreetInsider.com
www.streetinsider.com - August 3 at 4:07 PM
finance.yahoo.com logoHere's What's Pressuring Glaukos Corp Stock Today
finance.yahoo.com - August 3 at 4:07 PM
finance.yahoo.com logoGlaukos reports 2Q loss
finance.yahoo.com - August 3 at 4:07 PM
americanbankingnews.com logoGlaukos Corporation (NYSE:GKOS) Rating Reiterated by Piper Jaffray Companies
www.americanbankingnews.com - August 3 at 1:42 PM
americanbankingnews.com logoZacks: Brokerages Expect Glaukos Corporation (GKOS) Will Announce Earnings of $0.06 Per Share
www.americanbankingnews.com - August 3 at 12:12 PM
finance.yahoo.com logoGlaukos Corporation Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 2 at 8:37 PM
finance.yahoo.com logoGlaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : August 1, 2017
finance.yahoo.com - August 1 at 7:40 PM
finance.yahoo.com logoGlaukos Corp. – Value Analysis (NYSE:GKOS) : August 1, 2017
finance.yahoo.com - August 1 at 7:40 PM
americanbankingnews.com logoFinancial Analysis: Glaukos Corporation (NYSE:GKOS) vs. St Jude Medical (STJ)
www.americanbankingnews.com - July 31 at 10:25 PM
americanbankingnews.com logoReviewing Second Sight Medical Products (EYES) and Glaukos Corporation (NYSE:GKOS)
www.americanbankingnews.com - July 31 at 4:16 PM
americanbankingnews.com logoGlaukos Corporation (NYSE:GKOS) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 27 at 11:09 AM
americanbankingnews.com logoGlaukos Corp (GKOS) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - July 25 at 12:52 AM
finance.yahoo.com logoETFs with exposure to Glaukos Corp. : July 24, 2017
finance.yahoo.com - July 24 at 8:43 PM
nasdaq.com logoGlaukos (GKOS) Shares Cross Below 200 DMA - Nasdaq
www.nasdaq.com - July 22 at 12:28 AM

Social

Chart

Glaukos Corporation (GKOS) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff